15 Results for "

MV-1

" in MedChemExpress (MCE) Product Catalog:
Products (15)

15 Results for "MV-1" in MCE Product Catalog:

4
4 Cited Publications
製品番号: HY-122560
CAS 番号: 755002-90-5
Target:  

Potassium Channel

研究分野:  

Cardiovascular Disease

VU0134992 is the first subtype-preferring, orally active and selective Kir4.1 potassium channel pore blocker, with an IC50 of 0.97 µM. VU0134992 is 9-fold selective for homomeric Kir4.1 over Kir4.1/5.1 concatemeric channels (IC50=9 µM) at -120 mV .
4
4 Cited Publications
製品番号: HY-122560A
CAS 番号: 1052515-91-9
純度:  98.34%
Target:  

Potassium Channel

研究分野:  

Cardiovascular Disease

VU0134992 hydrochloride is the first subtype-preferring, orally active and selective Kir4.1 potassium channel pore blocker, with an IC50 of 0.97 µM. VU0134992 hydrochloride is 9-fold selective for homomeric Kir4.1 over Kir4.1/5.1 concatemeric channels (IC50=9 µM) at -120 mV .
2
2 Cited Publications
製品番号: HY-12981
CAS 番号: 920022-47-5
純度:  99.92%
別名: RO5028442
RG7713 (RO5028442) is a highly potent, selective and brain-penetrant Vasopressin 1a (V1a) receptor antagonist with Kis of 1 nM (hV1a) and 39 nM (mV1a).
製品番号: HY-113534
CAS 番号: 1001600-54-9
純度:  98.65%
Target:  

IAP Apoptosis

研究分野:  

Cancer

MV1 is an antagonist of IAP (inhibitor of apoptosis protein), leads to protein knockdown of HaloTag-fused proteins when combined with HaloTag ligand [1].
製品番号: HY-109024
CAS 番号: 1228088-30-9
純度:  99.89%
別名: RG7314
Balovaptan (RG7314) is an orally available, selective brain-penetrant vasopressin 1a (hV1a) receptor antagonist, with Kis of 1 and 39 nM for human (hV1a) and mouse (mV1a) receptors, and is used for the research of autism.
製品番号: HY-157485
CAS 番号: 339287-36-4
純度:  99.99%
Target:  

Potassium Channel

研究分野:  

Others

Ebio1 is a selective voltage-gated potassium channel KCNQ2 activator. Ebio1 activates KCNQ2 by generating an extended channel gate with greater conductance at a saturation voltage (+50 mV) .
製品番号: HY-123825
CAS 番号: 1432913-36-4
GX-674 is a potent, state-dependent, isoform-selective voltage-gated sodium channel 1.7 (Nav1.7) antagonist with an IC50 of 0.1 nM at -40 mV .
製品番号: HY-111886
Target:  

SNIPERs IAP

研究分野:  

Cancer

KHS108-MV1 is a conjugate of KHS108 and MV1. KHS108 is a ligand for TACC3. MV1 is an IAP antagonist that binds to cIAP1, cIAP2, and XIAP. KHS108-MV1 can be used in the research of breast cancer and fibrosarcoma [1].
製品番号: HY-111853
CAS 番号: 2095244-62-3
別名: PROTAC IAP binding moiety 2
Target:  

Ligands for E3 Ligase

研究分野:  

Cancer

MV-1-NH-Me, the MV-1 based IAP ligand, binds to ABL inhibitor via a linker to form SNIPER [1].
製品番号: HY-111858
Target:  

SNIPERs Bcr-Abl

研究分野:  

Cancer

SNIPER(ABL)-050, conjugating Imatinib (ABL inhibitor) to MV-1 (IAP ligand) with a linker, induces the reduction of BCR-ABL protein [1].
製品番号: HY-111854
Target:  

SNIPERs Bcr-Abl

研究分野:  

Cancer

SNIPER(ABL)-015, conjugating GNF5 (ABL inhibitor) to MV-1 (IAP ligand) with a linker, induces the reduction of BCR-ABL protein with a DC50 of 5 μM [1].
製品番号: HY-111873
Target:  

SNIPERs Bcr-Abl

研究分野:  

Cancer

SNIPER(ABL)-019, conjugating Dasatinib (ABL inhibitor) to MV-1 (IAP ligand) with a linker, induces the reduction of BCR-ABL protein with a DC50 of 0.3 μM [1].
製品番号: HY-111863
Target:  

SNIPERs Bcr-Abl

研究分野:  

Cancer

SNIPER(ABL)-047, conjugating HG-7-85-01 (ABL inhibitor) to MV-1 (IAP ligand) with a linker, induces the reduction of BCR-ABL protein with a DC50 of 2 μM [1].
製品番号: HY-168742
Target:  

Vasopressin Receptor

研究分野:  

Neurological Disease

V1a/V2 antagonist 1 (Compound 18j) is an orally active dual V1a and V2 receptor antagonist with high binding affinity for both receptors (Ki: 0.13 nM for hV1a, 0.53 nM for hV2 and 0.5 nM for mV1a; IC50: 2.2 nM for hV1a). V1a/V2 antagonist 1 inhibits Oxytocin (HY-17571)-induced scratching behavior in mice [1].
製品番号: HY-109024R
CAS 番号: 1228088-30-9
別名: RG7314 (Standard)
Balovaptan (Standard) is the analytical standard of Balovaptan (HY-109024). This product is intended for research and analytical applications. Balovaptan (RG7314) is an orally available, selective brain-penetrant vasopressin 1a (hV1a) receptor antagonist, with Kis of 1 and 39 nM for human (hV1a) and mouse (mV1a) receptors, and is used for the research of autism.
  • 1